Selarl Centre Ophtalmologique Rabelais Imagerie Laser Et Reeducation De La Basse Vision
- Address
- lock Available on a paid plan
Selarl Centre Ophtalmologique Rabelais - Advanced Retinal Disease Research
The Selarl Centre Ophtalmologique Rabelais is a specialized ophthalmological research center dedicated to advancing treatments for complex retinal conditions. With expertise in imaging, laser therapy, and low vision rehabilitation, the center conducts cutting-edge clinical research focused on preserving and restoring vision in patients with degenerative eye diseases.
- Geographic atrophy and age-related macular degeneration research
- Long-term safety evaluation of novel intravitreal therapeutic agents
- Advanced retinal imaging and diagnostic technologies
The center's research portfolio includes participation in extension studies evaluating emerging treatments such as avacincaptad pegol for geographic atrophy, demonstrating their commitment to understanding the long-term effects of innovative therapies. Through their comprehensive approach combining clinical research, advanced imaging capabilities, and rehabilitation services for low vision, the center provides a unique continuum of care for patients with progressive retinal diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Selarl Centre Ophtalmologique Rabelais Imagerie Laser Et Reeducation De La Basse Vision
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Open-Label Extension Study on the Safety of Intravitreal Avacincaptad Pegol in Geographic Atrophy Patients Post-GATHER2 Completion | Astellas Pharma Global Development Inc. | Phase III | Not Recruiting | Dec 2022 | Apr 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Avacincaptad Pegol | 1 | Unknown | 2022-12-21 | 2022-12-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.